HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL). | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute biphenotypic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Enrolling by invitation	Phase 2	2026-04-08		NCT07517510

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dongguan People's Hospital	32
First Affiliated Hospital of Guangxi Medical University	96
Guangdong Second Provincial General Hospital	22
Guangzhou First People's Hospital	32
Nanfang Hospital, Southern Medical University	248
Shenzhen Second People's Hospital	31
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	285
Zhongshan People's Hospital, Guangdong, China	46

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Hematology, Guangdong Second Provincial General Hospital	Guangzhou	China	4